[1]
|
Battino, D., Tomson, T., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., et al. (2013) Seizure Control and Treatment Changes in Pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry. Epilepsia, 54, 1621-1627.
http://dx.doi.org/10.1111/epi.12302
|
[2]
|
Cantwell, R., Clutton-Brock, T., Cooper, G., Dawson, A., Drife, J., Garrod, D., et al. (2011) Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 118, 1-203.
http://dx.doi.org/10.1111/j.1471-0528.2010.02847.x
|
[3]
|
Adab, N., Kini, U., Vinten, J., Ayres, J., Baker, G., Clayton-Smith, J., et al. (2004) The Longer Term Outcome of Children Born to Mothers with Epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 75, 1575-1583.
http://dx.doi.org/10.1136/jnnp.2003.029132
|
[4]
|
Cummings, C., Stewart, M., Stevenson, M., Morrow, J. and Nelson, J. (2011) Neurodevelopment of Children Exposed in Utero to Lamotrigine, Sodium Valproate and Carbamazepine. Archives of Disease in Childhood, 96, 643-647.
http://dx.doi.org/10.1136/adc.2009.176990
|
[5]
|
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., et al. (2011) Dose-Dependent Risk of Malformations with Antiepileptic Drugs: An Analysis of Data from the EURAP Epilepsy and Pregnancy Registry. The Lancet Neurology, 10, 609-617. http://dx.doi.org/10.1016/S1474-4422(11)70107-7
|
[6]
|
Shnayder, N.A., Dmitrenko, D.V., Sadykova, A.V., Sharavii, L.K., Shulmin, A.V., Shapovalova, E.A., et al. (2011) Epidemiological Studies on Epilepsy in Siberia. Medical and Health Science Journal, 6, 35-42.
http://dx.doi.org/10.15208/mhsj.2010.105
|
[7]
|
Harden, C.L., Meador, K.J., Pennell, P.B., Hauser, W.A., Gronseth, G.S., French, J.A., et al. (2009) Management Issues for Women with Epilepsy-Focus on Pregnancy (an Evidence Based Review): II. Teratogenesis and Perinatal Outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 50, 1237-1246.
http://dx.doi.org/10.1111/j.1528-1167.2009.02129.x
|
[8]
|
Shnayder, N.A., Pilyugina, M.S., Dmitrenko, D.V., Bochanova, E.N., Shapovalova, E.A., Erikalova, S.A., et al. (2011) Pharmacogenetics of Valproic Acid as Unmodified Risk Factor of Adverse Drug Reactions. Medical and Health Science Journal, 7, 20-28. http://dx.doi.org/10.15208/mhsj.2011.129
|
[9]
|
Fairgrieve, S.D., Jackson, M., Jonas, P., Walshaw, D., White, K., Montgomery, T.L., et al. (2000) Population Based, Prospective Study of the Care of Women with Epilepsy in Pregnancy. The British Medical Journal, 321, 675-674.
http://dx.doi.org/10.1136/bmj.321.7262.674
|
[10]
|
Adamyan, L.V., Kunkina, Yu.B., Zhidkova, I.A. and Kaznacheeva, T.V. (2009) Molecular Mechanisms of Epilepsy’s and Antiepileptic Therapy’s Influence on Woman’s Reproductive System (Review). Reproductive problems Journal, 2, 13-17. [Russian]
|
[11]
|
Grebenyuk, O.V., Svetlik, M.V. and Alifirova, V.M. (2013) Clinico-Electroencephalographic Predictors of Generalized Seizures Increasing in Gestational and Postnatal Periods. Bulletin of the Russian Academy of Medical Sciences Siberian Branch, 12, 24-30. [Russian]
|
[12]
|
Herndandez-Diaz, S., Smith, C.R., Shen, A., Mittendorf, R., Hauser, W.A., Yerby, M., et al. (2012) Comparative Safety of Antiepileptic Drugs during Pregnancy. Neurology, 78, 1692-1699.
http://dx.doi.org/10.1212/WNL.0b013e3182574f39
|
[13]
|
Kiseleva, L.G., Kalinina, L. and Chumakova, G.N. (2011) The Influence of Mother’s Antiepileptic Therapy on Condition of Fetus and Newborn. Vrach-Aspirant, 45, 363-372. [Russian]
|